Stay updated on Targeted Therapy for Incurable Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Targeted Therapy for Incurable Lung Cancer Clinical Trial page.

Latest updates to the Targeted Therapy for Incurable Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2. This appears to be a minor site version update with no changes to study details or key page elements.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedSystem update: Revision: v3.4.2 is now shown; the previous v3.4.1 notice about government funding lapses has been removed. Trial details, locations, eligibility, and outcomes remain unchanged.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding was added, informing users that updates may not be processed and directing to cc.nih.gov and opm.gov, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page now shows a glossary toggle, and the site revision is updated to v3.4.0. The update also adds the 'Last Update Submitted that Met QC Criteria' field and standardizes 'No FEAR Act' wording.SummaryDifference0.2%

- Check62 days agoChange DetectedPage revision metadata updated from v3.3.3 to v3.3.4; no study content or user-facing functionality appears altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded North Carolina to the Locations section as a study site. Removed the HHS Vulnerability Disclosure link and the 'North Carolina Locations' label; the page revision updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Targeted Therapy for Incurable Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Targeted Therapy for Incurable Lung Cancer Clinical Trial page.